Mesenchymal Stem Cells Ameliorate DSS-Induced Experimental Colitis by Modulating the Gut Microbiota and MUC-1 Pathway

PURPOSE: Mesenchymal stem cells (MSCs) have become novel therapeutic agents for the treatment of inflammatory bowel diseases (IBDs). However, the precise cellular and molecular mechanisms by which MSCs restore intestinal tissue homeostasis and repair the epithelial barrier have not been well elucida...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Han, Sun, Yang, Xiao, Feng-Jun, Zhao, Xia, Zhang, Wei-Yuan, Xia, Yu-Jun, Wang, Li-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184855/
https://www.ncbi.nlm.nih.gov/pubmed/37197438
http://dx.doi.org/10.2147/JIR.S402592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184855/
https://www.ncbi.nlm.nih.gov/pubmed/37197438
http://dx.doi.org/10.2147/JIR.S402592

Ejemplares similares